Radio Interview with our CEO: What Is Cancer Immunotherapy?
March 24, 2014 |
If you listen to the radio, you might have heard an interview recently with our CEO and director of scientific affairs, Dr. Jill O’Donnell-Tormey. She’s been talking on air to stations across the country about the breakthrough new treatments that harness the immune system’s power to fight cancer. One of the interviews has been published online, and we’re delighted to share it with you.
In the interview, which aired March 20, 2014, on the Tom Roten Morning Show at WVHU in Huntington, West Virginia, asks, "What is Cancer Immunotherapy?" and Dr. O’Donnell-Tormey explains why this new way to treat cancer is causing so much excitement and how oncologists are now beginning to use the other C word: cure.
Listen to the interview below or here: